RTVA — Artiva Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Artiva Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -3.99 | -18 |
| Depreciation | ||
| Non-Cash Items | 0.886 | 0.019 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.204 | 4.36 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -2.89 | -13.5 |
| Capital Expenditures | -0.272 | -0.284 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | -0.272 | -0.284 |
| Financing Cash Flow Items | 0 | -0.459 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 5.03 | 37.4 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 1.87 | 23.6 |